Constitutional Authority Statement for H.R. 5927; Congressional Record Vol. 166, No. 33
(House of Representatives - February 18, 2020)

Text available as:

Formatting necessary for an accurate reading of this text may be shown by tags (e.g., <DELETED> or <BOLD>) or may be missing from this TXT display. For complete and accurate display of this text, see the PDF.

[Page H1164]
From the Congressional Record Online through the Government Publishing Office []

            By Mr. POSEY:
        H.R. 5927.
        Congress has the power to enact this legislation pursuant 
     to the following:
        Article 1 Section 8 of the Constitution declares that 
     Congress has the power ``To regulate commerce with foreign 
     nations, and among the several states, and with the Indian 
     tribes;'' Article 2 Section 2 allows Congress to create other 
     executive officers. Finally, in Article 1, Section 8 
     clarifies that Congress has the right to make ``all Laws 
     which shall be necessary and proper for carrying into 
     Execution the foregoing Powers.''
        It is in keeping with the power invested in Congress under 
     these articles to direct the Secretary of Health and Human 
     Services (HHS) to study our dependence on Chinese 
     pharmaceuticals; direct HHS to provide recommendations for 
     weaning the American people off this dangerous dependence; 
     and authorize the U.S. Food and Drug Administration to issue 
     black-box warnings informing consumers of any risk they are 
     taking when using pharmaceuticals from countries with 
     systemic issues of supervision.